The inhalation therapy had been practiced by ancient civilizations in Egypt, India, Greece, and China. Proven records of use of the therapy for thousands of years are available. In order to resolve respiratory issues, the pulmonary method of administration has been effective in terms of confined and systemic supply of several drugs and biopharmaceuticals. The only reason for the lack of desired outcome or an unfavorable effect is inappropriate utilization of devices and improper training for handling of devices. At present, inhalation therapy is considered the best solution for lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The therapy permits the use of smaller doses and reduces systemic side-effects. Chronic obstructive pulmonary disease (COPD) is ranked by the World Health Organization (WHO) as one of the most prevalent long-term conditions in the world. The global burden of COPD is projected to rise in the near future, particularly in developing countries, due to increasing elderly population, growing habit of smoking, and rising pollution. Rising incidence of pulmonary diseases across the globe is a major factor fueling the global inhalation systems market.
The global inhalation systems market is primarily driven by rising prevalence of COPD, asthma, and chronic respiratory diseases; growing geriatric population facing chronic respiratory problems; and changing lifestyle. Moreover, introduction of novel and advanced pulmonary devices in customized shapes and sizes, availability of auto-injectors, and rise in research and developmental activities by pharmaceutical and biotechnology companies in order to develop novel oral and nasal drug formulations are some of the other important factors likely to drive the market from 2017 to 2025. However, complications and side-effects associated with drug inhalation, unavailability of a single effective inhaler device that can treat multiple disease indications, and lack of awareness are other factors restraining the market. Health care at home, campaigning by manufacturers and hospitals to increase awareness about respiratory diseases, and technological advancements are the current trends in the market for inhalation systems.
The global inhalation systems market has been segmented based on product, disease indication, end-user, and geography. Based on product, the market has been segmented into inhalers, nebulizers, nasal sprays, and others. The inhalers segment has been sub-divided into dry powder inhalers (DPIs), metered dose inhalers (MDIs), and multi-dose liquid inhalers. The nebulizers segment has been sub-segmented into ultrasonic nebulizers, compressed air-jet nebulizers, mesh nebulizers, and others. In terms of revenue, the inhalers segment is anticipated to hold a major share of the global inhalation systems market by 2025. It is expected to dominate the market from 2017 to 2025.
In terms of disease indication, the global inhalation systems market has been divided into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, anesthesia, nasal congestion, and others. According to a study conducted by the World Health Organization (WHO), chronic obstructive pulmonary disease was found to be the fifth cause of deaths globally in 2002 and is projected to be the fourth cause of mortality by 2030. Moreover, according to the WHO estimates, 65 million people have moderate to severe COPD. More than 3 million people died of COPD in 2005, which equaled to 5% of all deaths worldwide. Rising awareness about COPD and technological advancements in product offerings are major factors expected to fuel the COPD segment during the forecast period.
Based on end-user, the global inhalation systems market has been segmented into hospitals & clinics, ambulatory surgery centers, home care centers, and others. Among these, the home care centers segment is expected to register the maximum growth rate during the forecast period, owing to rising geriatric population, increasing per capita expenditure, and growing awareness about respiratory diseases. A survey conducted by the Healthcare First organization concludes that more than 3.4 million people in the U.S. receive Medicare skilled home health care services, due to rising elderly population and increasing incidence of chronic health conditions in the country. Geographically, the global inhalation systems market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market in the near future. The market in the region is likely to witness significant growth during the forecast period, owing to affordability of advanced products and rising prevalence of lifestyle-related diseases.
Key players operating in the global inhalation systems market are 3M, Boehringer Ingelheim GmbH, AptarGroup, Inc., Koninklijke Philips N.V., PARI GmbH, Trudell Medical International, Teleflex Incorporated, INSPIRO Medical Ltd., ALEXZA, and Monaghan Medical Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.